Anzeige
❌
Mehr »
Mittwoch, 14.10.2026 - Börsentäglich über 12.000 News
35 Millionen C$ Einsatz gegenüber 13 Millionen C$ erwartetem Gewinn für 2027
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
NN

WKN: A14MS1 | ISIN: DK0060580512 | Ticker-Symbol: 5NN
Frankfurt
14.10.26 | 08:04
4,885 Euro
+1,24 % +0,060
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
NNIT A/S Chart 1 Jahr
5-Tage-Chart
NNIT A/S 5-Tage-Chart
RealtimeGeldBriefZeit
4,7855,36008:46

Aktuelle News zur NNIT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.10.NNIT A/S: Process for potential divestment of SCALES A/S239NNIT A/S has noticed certain rumours in the market and confirms that it is exploring to potentially divest its subsidiary SCALES A/S. Nordea Corporate Finance has been appointed to assist in that process....
► Artikel lesen
28.08.Earnings Call Transkript: NNIT hält Gewinn in Q2 2026 trotz Umsatzrückgangs stabil3
28.08.NNIT Q2 2026 slides: revenue falls but margins hold amid transformation1
28.08.NNIT A/S H1 Loss Rises3
27.08.NNIT A/S: NNIT A/S: Q2 performance on track - strategy update setting direction for transformation296Q2 2026 key highlights NNIT's financial performance was in line with initial expectations, despite continued customer caution, particularly within the life science segments. However, order entry improved...
► Artikel lesen
12.05.NNIT A/S: NNIT A/S: Challenging start to the year and moderate order entry amid geopolitical turmoil216Q1 2026 key highlights NNIT's financial performance and order entry were below initial expectations reflecting continued geopolitical turmoil and sustained customer caution, particularly within the...
► Artikel lesen
07.05.NNIT A/S: NNIT Updates 2026 Outlook And Releases Preliminary Financial Figures For Q1 2026379May 7, 2026 NNIT UPDATES 2026 OUTLOOK AND RELEASES PRELIMINARY FINANCIAL FIGURES FOR Q1 2026 NNIT's financial performance and order entry were below initial expectations in Q1 2026, reflecting continued...
► Artikel lesen
24.04.NNIT A/S: NNIT updates its financial disclosure2
NNIT Aktie jetzt für 0€ handeln
17.03.NNIT A/S: New CEO to lead NNIT into its next phase of growth360NNIT A/S today announces that Claus Rydkjær has been appointed Chief Executive Officer, joining the company as of April 7, 2026. Claus Rydkjær will succeed Pär Fors, who in January announced his decision...
► Artikel lesen
12.03.NNIT A/S: Resolutions from the annual general meeting of NNIT A/S232Today, NNIT A/S (the "Company") held its annual general meeting, at which the following were noted/approved: Financial years 2025 and 2026 The Chairman of the Board gave the Board of Directors' report...
► Artikel lesen
15.01.NNIT A/S: CEO Pär Fors will leave NNIT274NNIT A/S hereby announces that Pär Fors, CEO, after almost 5 years in the role, has decided to leave NNIT A/S due to personal family matters. Pär Fors will continue in the CEO role until the end of...
► Artikel lesen
22.12.25NNIT A/S: NNIT Updates 2025 Outlook And Suspends Mid-term Financial Aspirations286NNIT updates its financial outlook for 2025 as market and customer activity have slowed down and performance improvements have not accelerated and materialized as expected. Furthermore, the group's...
► Artikel lesen
04.11.25NNIT A/S: On-track performance with doubled profitability298Q3 2025 key highlights While business was still being negatively impacted by macroeconomic and geopolitical uncertainty, there was an uplift in financial performance in the third quarter. Group operating...
► Artikel lesen
29.10.25NNIT A/S: NNIT restates its life science segment in its financial reporting structure420Today, NNIT announces an update to its financial reporting structure to ensure that all Life Sciences customers are fully consolidated under Region Europe, US, and Asia. As a result, all Life Science...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1